NCT06587165View on ClinicalTrials.gov

Quantifying New Heart Muscle Cells

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 23, 2015

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Tetralogy of Fallot With Pulmonary StenosisHeart Failure
Interventions
OTHER

N15-thymidine

50mg/kg (oral administration)

Trial Locations (1)

10065

RECRUITING

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

California Institute of Technology

OTHER

lead

Weill Medical College of Cornell University

OTHER